Life Sciences Push Agilent Q2 Revenues up 32 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today reported a 32 percent jump in fiscal second-quarter revenues year over year, with its Life Sciences segment seeing a 39 percent spike.

The company reported total revenues of $1.68 billion for the three months ended April 30, up from $1.27 billion a year ago, beating Wall Street expectation of $1.6 billion. Excluding the effects of acquisitions and divestitures, revenues rose 21 percent in the quarter year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.